SintilimabHyperprogressive advanced non-small-cell lung cancer : case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1964卷 / 1期
关键词：
D O I：
10.1007/s40278-023-42937-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：379 / 379
相关论文
共 50 条
  • [21] Concomitant radiochemotherapy of advanced non-small-cell lung cancer
    Fietkau, R
    LUNG CANCER, 2001, 33 : S65 - S76
  • [22] Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer
    Lau, Sally C. M.
    Batra, Ullas
    Mok, Tony S. K.
    Loong, Herbert H.
    DRUGS, 2019, 79 (08) : 823 - 831
  • [23] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [24] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    LUNG CANCER, 2012, 77 : S13 - S14
  • [25] Optimal chemotherapy in advanced non-small-cell lung cancer
    Pohl, G
    Malayeri, R
    Doweik, L
    Minar, W
    Pirker, R
    LUNG CANCER: CURRENT TOPICS, 2001, : 125 - 133
  • [26] CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCER
    WALLING, J
    RESPIRATORY MEDICINE, 1994, 88 (09) : 649 - 657
  • [27] Targeted therapy in advanced non-small-cell lung cancer
    Gettinger, Scott
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 29 (03) : 291 - 301
  • [28] Maintenance chemotherapy in advanced non-small-cell lung cancer
    Jassem, Jacek
    LANCET ONCOLOGY, 2012, 13 (03): : 217 - 218
  • [29] Immunotherapy in advanced non-small-cell lung cancer withEGFRmutations
    Liu, Fangfang
    Yuan, Xun
    Jiang, Jizong
    Chu, Qian
    IMMUNOTHERAPY, 2020, 12 (16) : 1195 - 1207
  • [30] Axitinib for the treatment of advanced non-small-cell lung cancer
    King, Judy W.
    Lee, Siow-Ming
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (06) : 765 - 773
12345